Patricia L. Morris

Array ( [id] => 5875422 [patent_doc_number] => 20060167041 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-27 [patent_title] => 'Imidazopyridine compound' [patent_app_type] => utility [patent_app_number] => 11/385786 [patent_app_country] => US [patent_app_date] => 2006-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20850 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20060167041.pdf [firstpage_image] =>[orig_patent_app_number] => 11385786 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5876093 [patent_doc_number] => 20060167265 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-27 [patent_title] => 'Process for making amlodipine, derivatives thereof, and precursors therefor' [patent_app_type] => utility [patent_app_number] => 11/385633 [patent_app_country] => US [patent_app_date] => 2006-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9036 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20060167265.pdf [firstpage_image] =>[orig_patent_app_number] => 11385633 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 281845 [patent_doc_number] => 07553845 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-30 [patent_title] => 'Substituted indolizine 1,2,3,6,7,8 derivatives, FGFs inhibitors, a method for the preparation thereof and pharmaceutical compositions containing said derivatives' [patent_app_type] => utility [patent_app_number] => 11/378972 [patent_app_country] => US [patent_app_date] => 2006-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18006 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/553/07553845.pdf [firstpage_image] =>[orig_patent_app_number] => 11378972 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5973096 [patent_doc_number] => 20110152326 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'SUBSTITUTED ARYLOXOETHYL CYCLOPROPANECARBOXAMIDE COMPOUNDS AS VR1 RECEPTOR ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 11/909843 [patent_app_country] => US [patent_app_date] => 2006-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24545 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20110152326.pdf [firstpage_image] =>[orig_patent_app_number] => 11909843 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5041251 [patent_doc_number] => 20070093533 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-26 [patent_title] => 'Crystalline S-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing same' [patent_app_type] => utility [patent_app_number] => 11/374034 [patent_app_country] => US [patent_app_date] => 2006-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4968 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20070093533.pdf [firstpage_image] =>[orig_patent_app_number] => 11374034 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5279351 [patent_doc_number] => 20090131483 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-21 [patent_title] => '2-PYRIDINE DERIVATIVES AS INHIBITORS OF NEUTROPHILE ELASTASE' [patent_app_type] => utility [patent_app_number] => 11/908746 [patent_app_country] => US [patent_app_date] => 2006-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21674 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20090131483.pdf [firstpage_image] =>[orig_patent_app_number] => 11908746 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4765866 [patent_doc_number] => 20080177078 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-24 [patent_title] => 'Conversion of 2-Pyrazolines to Pyrazoles Using Bromine' [patent_app_type] => utility [patent_app_number] => 11/885325 [patent_app_country] => US [patent_app_date] => 2006-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11449 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20080177078.pdf [firstpage_image] =>[orig_patent_app_number] => 11885325 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4814012 [patent_doc_number] => 20080194643 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-14 [patent_title] => 'Factor Xa Inhibitor Crystalline Forms' [patent_app_type] => utility [patent_app_number] => 11/909368 [patent_app_country] => US [patent_app_date] => 2006-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6980 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20080194643.pdf [firstpage_image] =>[orig_patent_app_number] => 11909368 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5754697 [patent_doc_number] => 20060223846 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-05 [patent_title] => 'Aza-bridged-bicyclic amino acid derivatives as alpha4 integrin antagonists' [patent_app_type] => utility [patent_app_number] => 11/370665 [patent_app_country] => US [patent_app_date] => 2006-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16819 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0223/20060223846.pdf [firstpage_image] =>[orig_patent_app_number] => 11370665 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5787113 [patent_doc_number] => 20060205950 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-14 [patent_title] => 'Process for the preparation of Tazarotene' [patent_app_type] => utility [patent_app_number] => 11/368486 [patent_app_country] => US [patent_app_date] => 2006-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3568 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0205/20060205950.pdf [firstpage_image] =>[orig_patent_app_number] => 11368486 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4846461 [patent_doc_number] => 20080182869 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-31 [patent_title] => 'Method of Racemization of the R(-) Isomer of the (2-Chlorophenyl)-6,7-Dihydrothieno[3,2-C]Pyridine-5(4H)-Acetic Acid Methyl Ester' [patent_app_type] => utility [patent_app_number] => 11/885654 [patent_app_country] => US [patent_app_date] => 2006-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2567 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20080182869.pdf [firstpage_image] =>[orig_patent_app_number] => 11885654 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9427720 [patent_doc_number] => 08703795 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-22 [patent_title] => 'Thienopyridine compounds, and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/367969 [patent_app_country] => US [patent_app_date] => 2006-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34085 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11367969 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5632601 [patent_doc_number] => 20060149071 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-06 [patent_title] => 'New methods for the synthesis of alfentanil, sufentanil, and remifentanil' [patent_app_type] => utility [patent_app_number] => 11/362498 [patent_app_country] => US [patent_app_date] => 2006-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14486 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0149/20060149071.pdf [firstpage_image] =>[orig_patent_app_number] => 11362498 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5429109 [patent_doc_number] => 20090088419 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-02 [patent_title] => 'PYRIDYL ACETIC ACID COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 11/817088 [patent_app_country] => US [patent_app_date] => 2006-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24559 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20090088419.pdf [firstpage_image] =>[orig_patent_app_number] => 11817088 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 44555 [patent_doc_number] => 07777044 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-17 [patent_title] => 'Process for the preparation of optically active derivatives of 2-(2-pyridylmethylsulfinyl)-benzimidazole via inclusion complex with 1,1′-binaphthalene-2,2′diol' [patent_app_type] => utility [patent_app_number] => 11/817624 [patent_app_country] => US [patent_app_date] => 2006-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3875 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/777/07777044.pdf [firstpage_image] =>[orig_patent_app_number] => 11817624 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4753503 [patent_doc_number] => 20080161579 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-03 [patent_title] => 'Process for Synthesis of Proton Pump Inhibitors' [patent_app_type] => utility [patent_app_number] => 11/816604 [patent_app_country] => US [patent_app_date] => 2006-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2246 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20080161579.pdf [firstpage_image] =>[orig_patent_app_number] => 11816604 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5324558 [patent_doc_number] => 20090062548 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'NOVEL PYRIDINE OXIDE COMPOUND, AND PROCESS FOR PRODUCING CARBOXYLIC ACID DERIVATIVE AND OPTICALLY ACTIVE CARBOXYLIC ACID DERIVATIVE WITH THE USE OF THE SAME' [patent_app_type] => utility [patent_app_number] => 11/816562 [patent_app_country] => US [patent_app_date] => 2006-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4062 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20090062548.pdf [firstpage_image] =>[orig_patent_app_number] => 11816562 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5656591 [patent_doc_number] => 20060142327 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => 'BETA 3 ADRENERGIC AGONISTS' [patent_app_type] => utility [patent_app_number] => 11/276192 [patent_app_country] => US [patent_app_date] => 2006-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12701 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20060142327.pdf [firstpage_image] =>[orig_patent_app_number] => 11276192 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5656593 [patent_doc_number] => 20060142329 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => 'BETA 3 ADRENERGIC AGONISTS' [patent_app_type] => utility [patent_app_number] => 11/276201 [patent_app_country] => US [patent_app_date] => 2006-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12713 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20060142329.pdf [firstpage_image] =>[orig_patent_app_number] => 11276201 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5656592 [patent_doc_number] => 20060142328 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => 'BETA 3 ADRENERGIC AGONISTS' [patent_app_type] => utility [patent_app_number] => 11/276198 [patent_app_country] => US [patent_app_date] => 2006-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12705 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20060142328.pdf [firstpage_image] =>[orig_patent_app_number] => 11276198 [rel_patent_id] =>[rel_patent_doc_number] =>)